Genocea Biosciences Balance Sheet - Quarterly (NASDAQ:GNCA)

Add to My Stocks
$0.5 $0.01 (1.96%) GNCA stock closing price Sep 18, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Genocea Biosciences stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Genocea Biosciences stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. The Genocea Biosciences balance sheet for 2018 Q2 shows total assets of $49.04M. The company has a asset turnover ratio of 0. Also see: Genocea Biosciences revenue and Genocea Biosciences operating cash flow for the same quarter.

View and download Genocea Biosciences quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash44.22M51.17M12.27M21.98M35.22M34.13M27.42M26.41M18.26M38.04M
Marketable Securities-----14.53M35.93M49.04M67.7M57.92M
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.27M1.37M-1.3M1.72M1.44M--1.34M1.56M
Total Current Assets
45.48M52.55M13.08M23.29M36.95M50.11M64.28M76.41M87.31M97.53M
Property Plant & Equipment--8.02M---9.03M---
Accumulated Depreciation--4.56M---4.16M---
Net Property Plant & Equipment
3.07M3.17M3.46M4M4.9M4.78M4.87M5.03M4.87M4.75M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets-------1.42M--
Total Assets
49.04M56.46M17.48M28.04M42.61M55.64M69.89M82.86M92.86M102.65M
Notes Payable----------
Accounts Payable1.66M2.09M3.51M2.12M2.46M2.87M3.04M1.88M1.11M2.15M
Current Portion Long-Term Debt1.92M-6.65M6.53M6.41M4.77M3.14M1.55M--
Current Portion Capital Leases----------
Accrued Expenses3.08M4.42M5.6M6.32M3.58M2.44M4.17M3.64M3.04M2.91M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
6.66M6.52M15.77M14.98M12.46M10.08M10.37M7.08M4.16M5.06M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt12.54M13.87M7.65M9.24M10.79M12.31M13.8M15.27M16.71M16.59M
Non-Current Capital Leases----------
Other Long-Term Liabilities15.98M21.5M--------
Total Liabilities
35.18M41.89M23.53M24.35M23.4M22.56M24.35M22.52M20.99M21.66M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus297.6M293.86M258.11M257.11M255.77M254.27M252.99M251.76M250.5M248.62M
Retained Earnings-284.52M-280.08M-264.19M-253.46M-236.59M-221.21M-207.48M-191.44M-178.68M-167.66M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity13.87M14.56M-6.05M3.68M19.2M33.08M45.54M60.34M71.86M80.99M
Total Liabilities & Shareholders Equity49.04M56.46M17.48M28.04M42.61M55.64M69.89M82.86M92.86M102.65M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Genocea Biosciences stock price by looking at Genocea Biosciences historical stock prices. One can compare PE with industry average by looking at the Genocea Biosciences PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Genocea Biosciences owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for GNCA stock as of 2018 Q2 is $49.04M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Genocea Biosciences for the quarter 2018 Q2 total to $35.18M. Liabilities for a company like Genocea Biosciences include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Genocea Biosciences Balance Sheet - Key Ratios

Current ratio
6.83
Debt to equity ratio
1.04
Asset turnover ratio
0
Receivables turnover
0